Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler’s Disease, Uppsala University Hospital

類似資料

• Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia
  著者:: Cherif, Honar, 等
  出版事項: (2014)
• Clinical Features and Mutations in the ENG, ACVRL1, and SMAD4 genes in Korean Patients with Hereditary Hemorrhagic Telangiectasia
  著者:: Lee, Seung-Tae, 等
  出版事項: (2009)
• Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia
  著者:: Karlsson, Torbjörn, 等
  出版事項: (2016)
• Visceral manifestations in hereditary haemorrhagic telangiectasia type 2
  著者:: Abdalla, S, 等
  出版事項: (2003)
• Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1
  著者:: Snellings, Daniel A., 等
  出版事項: (2019)